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Background: Transmissible gastroenteritis coronavirus (TGEV) is an enteropathogenic coronavirus that causes
diarrhea in pigs, which is correlated with high morbidity and mortality in suckling piglets. Information remains
limited about the comparative protein expression of host cells in response to TGEV infection. In this study, cellular
protein response to TGEV infection in swine testes (ST) cells was analyzed, using the proteomic method of
two-dimensional difference gel electrophoresis (2D DIGE) coupled with MALDI-TOF-TOF/MS identification.
Results: 33 differentially expressed protein spots, of which 23 were up-regulated and 10 were down-regulated
were identified. All the protein spots were successfully identified. The identified proteins were involved in the
regulation of essential processes such as cellular structure and integrity, RNA processing, protein biosynthesis and
modification, vesicle transport, signal transduction, and the mitochondrial pathway. Western blot analysis was
used to validate the changes of alpha tubulin, keratin 19, and prohibitin during TGEV infection.
Conclusions: To our knowledge, we have performed the first analysis of the proteomic changes in host cell
during TGEV infection. 17 altered cellular proteins that differentially expressed in TGEV infection were identified.
The present study provides protein-related information that should be useful for understanding the host cell
response to TGEV infection and the underlying mechanism of TGEV replication and pathogenicity.
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Transmissible gastroenteritis virus (TGEV) is a member
of the Coronaviridae family [1]. The infection of TGEV
causes severe diarrhea in suckling piglets (about 2 weeks
old) and its lethality approaches 100%, which results in
enormous economic loss in swine-producing areas in
the world [2]. TGEV is an enveloped virus with a positive-
sense RNA genome of 28.5 kb. About two-thirds of the
TGEV genome encodes the replicase proteins (rep) at the
5′ end, and one-third of the genome encodes other viral
genes at the 3′ end in an order of 5′-S-3a-3b-E-M-N-7-3′* Correspondence: fl@hvri.ac.cn
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reproduction in any medium, provided the or[3]. The genome of TGEV encodes four structural proteins:
spike (S), membrane (M,), minor envelope (E), and nucleo-
capsid (N) proteins. The surface protein S, a large type I
transmembrane glycoprotein that forms peplomers, is re-
sponsible for cell receptor binding and membrane fusion
[4]. The M protein spans the membrane and interacts with
the N protein to form core of the virus during assembly
[5,6]. The small E protein, a transmembrane protein
detected as a minor structural component, is essential for
TGEV replication [7]. The N protein, an internal phospho-
protein [8], interacts with the TGEV genomic RNA to form
viral nucleocapsid [5,9], and may disrupt host cell division
[10]. To date, there is limited information about host cell
responses to TGEV infection.
Proteomics analysis enables a more comprehensive
characterization of virus-virus and virus-host interactionsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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opment of proteomic approaches have greatly facilitated
detection of proteins induced in virus infected cells.
Among those techniques for differentially expressed
protein spot analysis, two-dimensional difference gel
electrophoresis (2D DIGE) is reproducible and sensitive
[13]. 2D DIGE has greatly facilitated the comparison of
two samples by removing gel-to-gel variability and by
using dyes (CyDye) with a greater dynamic range than
traditionally used silver or Coomassie stains [14]. Using
2D DIGE method followed by mass spectrometry (MS)
identification, comparative proteomics of host cells have
been investigated during virus infection, including hu-
man influenza A virus [15], human immunodeficiency
virus type 1 (HIV-1) [16], hepatitis B virus [17], hepatitis
C virus (HCV) [18], Epstein-Barr virus (EBV) [19], and
Dengue virus (DENV) [20], and porcine reproductive
and respiratory syndrome (PRRSV) [21]. Proteomics
method analyzing host cellular responses to TGEV infec-
tion can be used to identify important cellular factors in-
volved in viral pathogenesis.
In present study, to determine protein profiles of swine









Figure 1 Cytopathic effect caused by TGEV infection and identifica
cytophatic effect induced by the TGEV virus was analyzed by optical m
40× objective (A). The N protein in TGEV-infected and mock-infected S
the method of Western blot (B). T + and T- represent the TGEV infectedinfection, fluorescent 2D DIGE coupled with a MALDI-
TOF-TOF/MS identification proteomics approach was
utilized. A total of 33 differentially expressed protein
spots were identified, and those proteins of interest
were confirmed by Western blot. This study can provide
useful clues for better understanding of TGEV replication
and pathogenesis.
Results
Confirmation of TGEV propagation in ST cells
To obtain a detailed comparison of differences in protein
expression, the cellular proteins were extracted at 24 h,
48 h and 72 h p.i. from the TGEV-infected and mock-
infected ST cells and were identified by IFA and Western
blot analysis using mAb to N protein of TGEV as primary
antibody. IFA and Western blot analysis revealed that the
ST cells infected with TGEV could be recognized with
mAb to N protein of the TGEV at 24 h, 48 h and 72 h p.i.
(Figure 1). To determine the host response of ST cells fol-
lowing TGEV infection, the cytophatic effect (CPE) was
also observed at 24 h, 48 h, and 72 h p.i. TGEV induced
significant CPE at 48 h and 72 h p.i., characterized by
rounding and detachment of the cells (Figure 1A). TGEV- h 72 h
+48 T-72 T+72
N
tion of the TGEV infected and non-infected ST cells. The
icroscopy, at 24 h, 48 h and 72 h p.i. Images were taken with a
T cells were checked using the mAb to N protein of the TGEV by
and uninfected ST cells, respectively.
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proteomics analysis, in which a high percentage of TGEV-
infected cells showed considerable cell death.
Analysis of differentially expressed proteins after TGEV
infection
To identify cell proteins involved in response to TGEV
infection, 2D DIGE proteomics method was performed.
Three independent experimental repeat of TGEV-
infected and mock-infected ST cells were included in
this analysis (Additional file 1: Figure S1). After 2D
DIGE, the Cy2, Cy3, and Cy5 channels of each gel were
individually imaged, and were analyzed using Decyder
software package (version 6.04.11, GE Healthcare). For
proteins separated in the pH 4–7 range, 2,710 protein































Figure 2 Differentially expressed protein spots (marker with master num
are labeled with Cy3 (red), the mock-infected ST cells are labeled with Cy5 (blu
Representative data from a 2D DIGE (B).modified between the TGEV-infected and mock-infected
ST cells (2-fold difference in abundance and p < 0.05), in-
cluding 23 spots that were up-regulated and 10 that were
down-regulated (Figure 2 and Figure 3).
Mass spectral identification of differentially expressed
proteins
To identify the differentially expressed proteins in TGEV-
infected ST cells, a total of 33 protein spots with a thresh-
old greater than 2-fold were excised manually from gels
and subjected to in-gel trypsin digestion and subsequent
MALDI-TOF/TOF identification. As shown in Figure 4
and Table 1, 33 differentially expressed protein spots
(Additional file 2: Table S1), comprising 23 up-regulated
and 10 down-regulated protein spots, were successfully











bers) displayed in 2D DIGE images. The TGEV-infected ST cell lysates
e), the internal standard proteins are labeled with Cy2 (yellow) (A).




















Protein biosynthesis and modification
Vesicle transport
Mitochondrion associated protein Signal transduction
Metabolism
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Figure 3 Image of ImageQuant and DeCyder analysis of 35 differentially expressed protein spots in 2D DIGE gels. T + and T- represent
TGEV-infected and mock-infected ST cells, respectively.
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Figure 4 Pie chart representing differentially expressed proteins identified by mass spectrometry following TGEV infected ST cells.
Proteins were classified according to their subcellular location (A) and biological function (B).
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tion and subcellular annotations from the Swiss-Prot and
TrEMBL protein database and Gene Ontology Database,
the identified cellular proteins were comprised of cellular
structure and integrity, RNA processing, protein biosyn-
thesis and modification, vesicle transport, signal transduc-
tion, and mitochondrial pathway.
Thirty-three differential protein spots corresponded to
17 proteins, including cytoskeleton-associated proteins
(35.3%), protein biosynthesis and modification proteins
(17.6%), RNA processing proteins (11.8%), vesicle trans-
port proteins (11.8%), mitochondria-associated proteins
(5.9%), signal transduction-associated proteins (5.9%),
and 5.9% metabolism-associated proteins. These proteins
(Figure 3) were mainly located in the cytosol (64.7%),
membrane (11.8%), nucleus (11.8%), and mitochondrion
(11.8%). In addition, some different spots were identified
to be products of the same gene, including beta actin,
alpha tubulin, vimentin, eukaryotic initiation factor 4A-I,
and thiopurine S-methyltransferase. In particular, 7 pro-
tein spots (6 up-regulated spots and 1 down-regulated
spot) were identified as beta actin, and 8 protein spots
(5 up-regulated spots and 3 down-regulated spots) were
identified as vimentin.
Analysis of identified proteins at the transcriptional level
Alterations in expression of a protein may be due to a
change in its mRNA level. In order to confirm the re-
sults of the proteomics analysis at the mRNA level, the
transcriptional alterations in six selected proteins were
measured by real-time RT-PCR. Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) gene was used as a control
housekeeping gene. The mRNA level of ANXA8 was de-
creased in TGEV-infected ST cells (Figure 5). The mRNA
level of KRT19, TPMT, LDHB, PP2A, UQCRC1 were in-
creased in TGEV-infected ST cells (Figure 5). The trends
of change in the mRNA level of ANXA8, TPMT, LDHB,
PP2A, and UQCRC1 were consistent with 2D DIGEresults. Interestingly, KRT19 had contrary results to with
those of 2D DIGE methods. These data provide transcrip-
tional information complementary to those differentially-
expressed proteins detected by 2D DIGE analysis.
Protein validation by western blot
To further verify those proteins identified by 2D DIGE
and MALDI-TOF/TOF mass spectrometry, Western blot
analyses were performed. Three proteins, alpha tubulin,
keratin 19, and prohibitin were selected for western blot
analysis. Equal amounts of cell lysates from TGEV-
infected and mock-infected ST cells at 48 h p.i. were ex-
amined with specific antibodies to alpha tubulin, keratin
19, and prohibitin. The data showed in Figure 6 indicate
that alpha tubulin, keratin 19, and prohibitin were recog-
nized with respective antibodies. From Figure 6, we can
see that keratin 19 was down-regulated and alpha tubu-
lin and prohibitin were up-regulated, which was consist-
ent with the 2D DIGE analysis. These data validated the
MALDI-TOF/TOF identification of those proteins in
TGEV-infected ST cells that differentially expressed.
Discussion
Proteomics is a novel methodology to detect components
of cellular protein interactions as well as host cellular
pathophysiological processes that occur during virus in-
fection [11]. Until present investigation, no results have
been reported for performing analysis of differential
proteome of host cells infected with TGEV. In this study,
2D DIGE coupled with MALDI-TOF/TOF was used to
analyze the differential proteome of ST cells infected with
TGEV. The 33 differential protein spots were successfully
identified as 17 proteins, of which function in diverse
biological processes.
Cytoskeletal protein expression was altered in TGEV-
infected ST cells. The cytoskeleton filaments are dy-
namic and divided into three types: microfilaments
(actin filament), microtubules, and intermediate filaments
Table 1 Proteins identified from the differential 2D DIGE analysis after TGEV infection
Spot
numbera
















1154 beta actin (ACTB) gi|45269029 44.76 5.55 3 36 285 3.64 0.000035
1308 beta actin (ACTB) gi|45269029 44.76 5.55 3 16 407 4.04 0.00013
1312 beta actin (ACTB) gi|45269029 44.76 5.55 3 14 129 −2.82 0.00076
1368 beta actin (ACTB) gi|45269029 44.76 5.55 1 16 82 4.68 0.0097
1383 beta actin (ACTB) gi|45269029 44.76 5.55 5 34 537 3.7 0.0019
1647 beta actin (ACTB) gi|150438831 44.76 5.55 3 21 242 7.03 0.005
1675 alpha tropomyosin (TPM1) gi|158931149 32.69 4.71 5 46 544 −2.82 0.0027
1864 beta actin (ACTB) gi|476332 26.10 5.55 3 35 177 2.58 0.00023
Microtubule-associated proteins
911 alpha Tubulin (TUBA1B) gi|116256086 50.12 4.94 4 28 340 9.08 0.0029
964 beta Tubulin (TUBB) gi|75045190 49.64 4.78 7 31 448 2.28 0.00081
978 alpha Tubulin (TUBA1B) gi|116256086 50.12 4.94 3 32 338 3.38 0.000014
Intermediate filament proteins
1078 vimentin (VIM) gi|335296459 53.64 5.06 6 64 1020 −3.26 0.0001
1266 vimentin (VIM) gi|335296459 53.64 5.06 6 60 888 −4.28 0.00013
1892 vimentin (VIM) gi|335296459 53.64 5.06 2 35 389 −2.82 0.00041
1947 vimentin (VIM) gi|335296459 53.64 5.05 4 35 582 4.84 0.000014
1968 vimentin (VIM) gi|21431723 30.97 4.67 4 25 366 3.06 0.00036
1970 vimentin (VIM) gi|335296459 53.64 5.06 4 35 603 2.43 0.00082
1907 keratin 19 (KRT19) gi|311267276 44.19 5.05 8 47 682 −3.99 0.000023
2090 vimentin (VIM) gi|21431723 30.97 4.67 2 9 120 5.63 0.0095





gi|335296158 104.85 5.85 3 7 277 −3.26 0.011
1803 thiopurine S-methyltransferase
(TPMT)
gi|311259781 28.46 5.46 5 41 497 3.59 0.000099
2023 thiopurine S-methyltransferase
(TPMT)
gi|311259781 28.46 5.46 5 54 476 6.96 0.000008
Protein biosynthesis and modification
716 protein phosphatase 2A (PP2A) gi|510469 65.28 5.00 2 30 239 2.71 0.0051
1116 eukaryotic initiation factor 4A-I
(EIF4A1)
gi|154147660 46.13 5.32 7 44 586 3.87 0.00052
1158 eukaryotic initiation factor 4A-I
(EIF4A1)
gi|154147660 46.13 5.32 5 40 531 3.37 0.0011
1509 acidic ribosomal protein P0
(RPLP0)
gi|182705234 34.34 5.71 4 50 483 2.38 0.02
Vesicle transport
1602 annexin A8 (ANXA8) gi|194042330 36.71 5.20 6 63 752 −3.31 0.0063
1814 annexin A4 (ANXA4) gi|4033507 35.81 5.71 5 49 510 −5.96 0.000008
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Table 1 Proteins identified from the differential 2D DIGE analysis after TGEV infection (Continued)
Mitochondrion associated protein
906 cytochrome b-c1 complex
subunit 1 (UQCRC1)
gi|335299041 52.67 5.76 4 38 342 7.9 0.000023
1094 prohibitin (PHB) gi|335308255 28.88 5.74 6 72 688 3.04 0.0031
Signal transduction
1871 14-3-3 protein eta (YWHAH) gi|194043292 28.19 4.81 4 30 282 −2.52 0.00035
Metabolism
1640 L-lactate dehydrogenase B chain
(LDHB)
gi|164518958 36.42 6.73 2 22 126 5.74 0.0016
a Spot number correspond to the unique sample spot number as indicated Figure 2.
b Accession numbers according to NCBInr database.
c Number of peptides identified by MALDI-TOF/TOF is given by MASCOT.
d Protein scores greater than 59 were considered successfully identified (p < 0.05).
e Paired average volume ratio and p values (t test) between ST cells infected by TGEV versus uninfected cells (TGEV/mock) were quantified using DeCyder software.
Zhang et al. Proteome Science 2013, 11:31 Page 7 of 13
http://www.proteomesci.com/content/11/1/31[22]. The intermediate filaments can provide mechanical
stability to cells, while actin and microtubule cytoskeletons
are responsible for trafficking of numerous endogenous
cargos as well as intracellular microorganisms throughout
the cells [23]. Many viruses use the cytoskeleton for infec-
tion and replication, such as HIV-1 [24]. In present study,
differentially expressed microfilament-associated proteins
beta actin and alpha tropomyosin, microtubule-associated
alpha tubulin and beta tubulin, as well as the intermediate
filament-associated vimentin and keratin 19 were identified















































Figure 5 Transcript alteration of the differentially expressed
proteins in TGEV-infected ST cells. Total cellular RNA of ST cells
with or without TGEV infection at 48 h p.i. was measured by real
time RT-PCR analysis. Samples were normalized with GAPDH gene as
a control housekeeping gene. Error bars represent standard deviation.
Gene symbols indicating different genes refer to Table 1 or Table 2.The actin and microtubule cytoskeleton play import-
ant roles in the life cycle of viruses [25]. Numerous viral
proteins interact with actin-binding proteins or directly
with actin [26]. Microtubules and microtubule-associated
proteins are known to play important roles in intra-
cellular trafficking of viral components as well as vi-
rions in the infected host cell [23]. In this study, the
up-regulated microfilament-associated proteins beta
actin and microtubule-associated alpha tubulin and
beta tubulin were identified, which was believed to fa-
cilitate the transport of viral proteins of TGEV from
rough endoplasmic reticulum (ER) and Golgi appar-
atus to the reservoir for viral replication.
Vimentin is a major component of type III intermedi-
ate filaments found in many cell lines [27]. This protein
serves to maintain cell shape and is involved in attach-
ment, migration and cell signaling [28]. Major changes
in the distribution of vimentin are observed when the
cell moves and divides [29], but this protein is also
redistributed in cells expressing misfolded proteins and
during virus infection [30]. Previous studies have shown
that intermediate filament protein vimentin was cleaved
by human immunodeficiency virus type 1 protease
(HIV-1 PR) [31] and that vimentin networks collapsed and
was dispersed in IBDV-infected cells [32]. In present study,
8 differential protein spots were identified as vimentin in-
cluding 5 up-regulated protein spots and 3 down-regulated
protein spots. Further study is required to determine
whether TGEV papain-like protease 1 (PL1pro) [33] cleaves
vimentin into different isoform or subunit, using a similar
strategy as HIV.
Among those differentially expressed host proteins,
some are known to participate in viral replication and
translation (Table 1). Positive-strand RNA viruses must
recruit normal components of host cellular RNA pro-
cessing or translation machineries for viral RNA synthe-
sis and protein synthesis [34]. Heterogeneous nuclear
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Figure 6 (See legend on next page.)
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Figure 6 Western blot confirmation of representative proteins in TGEV-infected ST cells. Representative image of ImageQuant and
DeCyder analysis of keratin19, alpha tubulin, vimentin, and prohibitin in 2D DIGE gels (A). The immunoblot analysis of keratin19, alpha tubulin,
vimentin, and prohibitin in TGEV-infected and mock-infected ST cells (B). The averaged densitometric intensity of keratin19, alpha tubulin,
vimentin, and prohibitin in immunoblot analysis, with GAPDH as a loading control (C). T + and T- represent TGEV-infected and mock-infected ST
cells, respectively. PM, protein marker. Image view and 3-D view obtained from DeCyder.
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through a carboxy-terminal RGG sequence [35]. HNRNPU
is known to influence pre-mRNA processing, mRNA
transportation to cytoplasm, intracellular localization,
translation, and turnover of mRNAs [36]. Previous studies
have shown that the levels of HIV-1 viral transcripts are
dramatically down-regulated in cytoplasm of infected cells
by HNRNPU [37]. In this study, the down-regulated
HHRNPU was found after TGEV infection, which may
facilitate the replication of viruses. Another RNA pro-
cessing protein, thiopurine S-methyltransferase (TPMT),
was found to be more abundant in TGEV-infected cells.
TPMT is a cytoplasmic transmethylase present in pro-
karyotes and eukaryotes, which has a molecular mass of
28 kDa and comprises 245 amino acids [38]. TPMT is a
drug-metabolizing enzyme widely expressed in mamma-
lian and non-mammalian cells [39]. Previous works have
reported that TPMT plays a role in BVDV virus replica-
tion and thiopurines inhibit bovine viral diarrhea virus
production in a TPMT-dependent manner [40]. Based on
these data, an up-regulation of TPMT in TGEV-infected
ST cells suggests that this host protein plays an important
role in TGEV biology, making it possible target for future
drug development.
Viruses rely on the cellular translation machinery to
translate their own proteins, which facilitates the rapid
production of viral proteins and renders an inhibitory ef-
fect on the production of host proteins, including host
anti-viral proteins [41]. Translation factors have been
well documented as playing crucial roles in viral RNA
and protein synthesis [42]. In herpes simplex virus type
1 (HSV-1) infected HeLa cells, the synthesis of several
ribosomal proteins and their assembly into ribosomes
continue in spite of a general inhibition of cellular protein
synthesis [43]. Acidic ribosomal protein P0 (RPLP0) is
located in the active part of the ribosome particle, at
which mRNAs, tRNAs and translation factors interact
during protein synthesis [44]. The cellular RPLP0 was
observed as up-regulated after virus infection, such as
pseudorabies virus (PrV) infected bovine kidney cells
[45], and Epstein-Barr virus (EBV) infected primary B
cells [46]. In this study, the up-regulated 60S RPLP0 was
also found after TGEV infection, suggesting the ribosomal
protein plays an important role in the translation of TGEV
viral proteins.
Viruses may inhibit host protein synthesis by targeting
multiple steps in the gene expression process via variouspathways, for instance, the vesicular stomatitis virus
(VSV) M protein inhibits the initiation of the transcrip-
tion of host genes [47] and the SARS-CoV spike protein
inhibits host cell translation by interaction with eIF3f
[48]. In this study, the up-regulated eukaryotic initiation
factor 4A-I (EIF4A1) was identified after TGEV infec-
tion. The translation initiation proteins observed in TGEV
infected ST cells may be a reflection of translation regula-
tion mechanisms exploited by TGEV virus, interfering with
cellular protein synthesis and translation initiation of
the host cell for beneficial reasons, which need to be fur-
ther studied.
Protein phosphatase 2A (PP2A) is an evolutionarily con-
served enzyme that represents a major portion of serine/
threonine phosphatase activity in cell extracts [49]. PP2A
enzymes have been clearly involved in regulation of cell
transcription, cell cycle and viral transformation [50]. Up-
regulation of PP2A scaffold subunit A and subsequent de-
phosphorylation of Tyr-307 in the catalytic subunit was
found, suggesting PP2A activation in Huh7 infected cells
[51,52]. Activation of serine-threonine PP2A was found in
Huh7 cells upon HSV-1 infection, and PP2A activation
paralleled dephosphorylation and inactivation of the down-
stream mitogen-activated protein (MAP) kinase pathway
[53]. In this study, the up-regulation of PP2A was found in
TGEV infected ST cells, suggesting PP2A plays an import-
ant role in the dephosphorylation of cellular and viral pro-
tein during TGEV infection.
Several proteomics analysis about coronavirus had
been done including SARS-CoV [54], IBV [55,56], and
MHV [57]. By comparing the finding proteins in this
study to previous findings, there is no common gene of
target related to coronavirus. The findings in TGEV
infected ST cell might not reflect the interaction be-
tween the virus and pig intestine epithelial cell. It is
surprising that the proteome responses observed did
not reveal any immune responses related proteins in
TGEV-infected ST cells. It may be related to the host
cells chosen or the fact that attenuated TGEV strain
was used. Identification of cellular proteome in pig in-
testine epithelial cell or immune cells infected with
TGEV need to be further studied.
Conclusions
In conclusion, a total of 17 altered cellular proteins that
differentially expressed in TGEV infection were identified
in this study. Most of these proteins were involved in
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signal transduction, and alteration of the cytoskeleton net-
works. Western blot analysis of alpha tubulin, keratin 19,
and prohibitin validated the MALDI-TOF/TOF identifica-
tion of the differentially expressed proteins in the
TGEV-infected ST cells. The present study provides large
scale protein-related information that should be useful for
understanding the pathogenesis of TGEV infection.
Materials and methods
Cell culture, virus infection and sample preparation
The TGEV strain attenuated H (Accession NO. EU074218)
[58] was propagated on a ST cell monolayer. The proteins
of TGEV infected ST cells were extracted according to the
methods previously described [59]. Briefly, the ST cells
were infected with attenuated H (H167) at a multiplication
of infection (MOI) of 1, and the cells were scraped using a
cell scraper at 48 h postinfection (p.i.), and centrifuged at
10,000 × g for 5 min. After washing three times with ice-
cold phosphate-buffered saline (PBS), the collected cells
were lysed with lysis buffer (7 M urea, 2 M thiourea, 4%
[w/v] CHAPS, 65 mM DTT, 0.2% pharmalyte 4/7 and
1 mM PMSF) containing 1% nuclease mix in the final con-
centration and were vertically vibrated until the cells were
completely lysed. The supernatant was collected after cen-
trifuging at 12,000 × g at 4°C for 60 min. Samples were
treated with a 2D clean-up kit (GE Health Care) and a 2D
quant kit (GE Health Care) according to the instructions of
the manufacturers. Paralleled mock-infected ST cells were
used as control. Three biological replicates of TGEV-
infected and mock-infected ST cells were prepared.
2D DIGE
A total of 200 pmol of CyDye DIGE Flours (GE healthcare,
Germany) were used to label 50 μg of protein samples. To
access biological variation, three experimental duplicates
were carried out using the samples prepared above. The in-
ternal standards (equal amounts of both samples) were la-
beled with Cy2. Protein extracts from mock-infected ST
cells, used as a reference state, were labeled with Cy5. Pro-
tein extracts from TGEV-infected ST cells were labeled
with Cy3, representing the test states. IEF was performedTable 2 Primers used for real time RT-PCR







UQCRC1 GAAGGAAATTGACCAGGAGG GGGGCAusing an IPGphor system (GE Healthcare) and commer-
cially available 24-cm long IPG strips (Linear, pH 4–7, GE
Healthcare). The settings and conditions for active rehy-
dration of the IPG strips were used as previously described
[60]. Briefly, IEF was performed using the following param-
eters: 30 V, 12 h; 200 V, 1 h; 1,000 V, 1 h; 8,000 V, 2 h; and
8,000 V, 65,000 vh. The isoelectric-focused proteins in
strips were incubated for 15 min in the equilibration buffer
(6 M urea, 30% glycerol, 2% SDS, and 0.375 M Tris,
pH 8.8) containing 1% DTT, followed by additional equili-
bration for 15 min in the equilibration buffer containing
2.5% iodoacetamide. The second dimension separation was
performed using the Ettan Dalt II system (GE healthcare).
Gels were poured between low fluorescent glass plates, of
which one plate was bind-silane treated. Three parallel gels
were run at 12°C (running buffer: 25 mM Tris, 192 mM
glycine and 1% SDS). The equilibrated IPG strips were fur-
ther resolved with 12% SDS-PAGE gels at 1 W/gel for
30 min and then 6 W/gel until the dye front reached the
bottom of the gels.
Image acquisition and analysis of 2D DIGE gels
Cy2-labeled, Cy3-labeled, and Cy5-labeled protein im-
ages were scanned directly between the low fluorescent
glass plates using a Typhoon Variable Mode Imager
9400 (GE Healthcare) with the CyDye-specific settings
for excitation at 488 nm, 532 nm and 633 nm, and for
emission at 520 nm, 590 nm and 680 nm. All gels were
scanned with a resolution of 100 μm and a standard pixel
volume of 60,000-80,000 for all scans. Determination of
protein abundance and statistical analysis was performed
using the Decyder™ software package (version 6.04.11,
GE Healthcare). Inter-gel matching performed using
the Biological Variation Analysis (BVA) mode. Matching
between gels was performed using the in-gel standard from
each image pair. A paired t test was used for the methods
of statistical analysis. Only protein spots showing signifi-
cance (p < 0.05) and at least a 2-fold difference in abun-
dance (ratio of the mean of the normalized spot volume of
the TGEV-infected samples versus mock-infected samples)
were considered as up-regulated (ratio > 2) or down-
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spectrometry (MS) and a database search
For identification of protein spots a preparative gel
containing 800 μg of protein was run as described
above and stained with PhastGel™ Blue R (GE Healthcare).
The protein spots of interest were manually excised from
the gels and plated into 96-well microplates. Excised spots
were firstly destained twice with 60 μl of 50 mM
NH4HCO3 and 50% acetonitrile (ACN) and then dried
twice with 60 μl of ACN. Afterwards, the dried pieces of
gels were incubated in ice-cold digestion solution (trypsin
12.5 ng/μl and 20 mM NH4HCO3) for 20 min and then
transferred into a 37°C incubator for digestion overnight.
Finally, peptides in the supernatant were collected after
extraction twice with 60 μl extract solution (0.1% TFA in
50% ACN). The peptide solution was dried under the
protection of N2, and 0.8 μl matrix solution (5 mg/ml α-
cyano-4-hydroxy-cinnamic acid diluted in 0.1%TFA, 50%
ACN) was pipetted to dissolve it. Then the mixture was
spotted on a MALDI target plate (Applied Biosystems).
MS analysis of peptides was performed on an AB SCIEX
5800 MALDI-TOF/TOF. The UV laser was operated at a
400 Hz repetition rate with wavelength of 355 nm. The
accelerated voltage was operated at 20 kV and mass reso-
lution was maximized at 1,600 Da. Myoglobin digested
with trypsin was used to calibrate the mass instrument
with an internal calibration mode. All acquired spectra
from samples were processed using TOF/TOF Explore™
Software in a default mode. The data were searched by
GPS Explorer (V3.6) with the search engine MASCOT
(2.1). The following parameters were used in the search:
National Center for Biotechnology information non-
redundant (NCBInr) database (release date, July, 2011),
Sus scrofa, protein molecular mass ranged from 700 to
3,600 Da, trypsin digest with one missing cleavage, pep-
tide tolerance of 100 ppm,MS/MS tolerance of 0.8 Da
and possible oxidation of methionine. Known contam-
inant ions (tryptic autodigest peptides) were excluded.
A total of 41,373 sequences and 16,019,616 residues in
the database were actually searched. All identified
proteins had a protein score greater than 59, corre-
sponding to a statistically significant (p < 0.05) confident
identification. Besides protein score, at least one ion
score with p < 0.05 was recommended to increase the
reliability of identifications.
Western blot
Samples of TGEV-infected and mock-infected ST cells
were lysed at 48 h p.i., and the protein concentration
was determined. Equivalent amounts of cell lysates
(60 μg) were subjected to 12% SDS-PAGE gels and
then transferred to 0.22 μm nitrocellulose membranes
(Hybond-C extra, Amersham Biosciences). After blotting,
the membranes were incubated with mouse monoclonalantibody (mAb) to alpha tubulin (1:1000, Abcam), mAb to
prohibitin (1:500, II-14-10, Santa Cruz), and rabbit poly-
clonal antibody to keratin19 (1:500, Bioss) at 37°C for
60 min. After washing three times with PBST, the mem-
branes were inoculated with horseradish peroxidase (HRP)
conjugated goat anti-mouse IgG (Kirkegaard & Perry
Laboratories, Inc.) or goat anti-rabbit IgG (Kirkegaard &
Perry Laboratories, Inc.) at 37°C for 60 min and visu-
alized using 3,3′,5,5′-tetramethylbenzidine-stabilized sub-
strate (TMB, Promega).Real time RT-PCR
Total RNA was extracted from the ST cells, which were
infected with TGEV for 48 h, using the EZ-10 Spin Col-
umn RNA Purification Kit (Qiagen) according to the man-
ufacturer’s protocol. cDNA synthesis was performed with
1 μg of total cellular RNA using a RevertAid™ first strand
cDNA synthesis kit (Fermentas), according to manufac-
turer’s protocol. The specific primers for amplifying various
target genes for differentially expressed proteins were
designed according to the available gene sequences depos-
ited in GenBank using Lasergene sequence analysis soft-
ware (DNAStar, Inc., Madison, WI, USA) (Table 2). Real
time RT-PCR was performed using a LightCycler 480 II
(Roche) in a total volume of 20 μL containing 10 ng of
cDNA template, 1 × SYBR® Premix Ex Taq™ II (Perfect Real
Time, TaKaRa), and a 0.4 μM concentration of each pri-
mer. After initial denaturation at 95°C for 2 min, the ampli-
fication was performed for 40 cycles, each consisting of
denaturation at 95°C for 5 s and primer annealing at 55°C
for 15 s. Melting curves were obtained, and quantitative
analysis of the data was performed in a relative quantifica-
tion (2-ΔΔCT) study model. Parallel mock-infected ST cells
were used as control (relative expression = 1) and GAPDH
as an internal reference gene.Additional files
Additional file 1: Figure S1. MS and MS/MS spectra of the identiifed
protein spots.
Additional file 2: Table S1. Cell proteins identified from the differential
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